Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa [Yahoo! Finance]
Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript [Seeking Alpha]
Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment [MSNBC.com]
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment [MSNBC.com]
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment [CNBC]